eCOA+ for better evidence generation

Better data in real time

eCOAs and digital outcome measures delivered at industry-leading speed and quality to enhance your trial findings and fuel medical breakthroughs.

eCOA+ is part of Medable's unified data collection platform, which includes eConsent, telehealth, and sensors, with standardized integrations into your existing clinical ecosystem.

Medable eCOA+

50%

Faster study build time

400+

Pre-built and validated instruments

120+

Available languages

Medable user holding ipad

Connected and convenient

Make data collection a breeze with devices, diaries, and sensors designed to fit into participants’ everyday lives.

Remove manual entry and configuration time with intuitive and automated workflows for sites and study teams.

Take eCOA off the critical path

Rapidly deploy quality studies and take eCOA off the critical path of study start-up with a reusable instrument library of 380+ standardized workflows and AI-enabled, purpose-built technology so you can work on what matters most, advancing patient care.

Unlock insights with real-time data capture

Capture objective and subjective participant data in a standardized and compliant manner. Medable’s eCOA+ combines eClinROs, ePROs, ePerfOs, eObsROs, and digital measures, so you can uncover clinically meaningful insights in real-time.

Engage patients with a better experience

Medable’s eCOA+ improves inclusivity and accessibility, meeting the needs of patients in any geographic location and across diverse therapeutic areas, reducing burden and increasing retention.

The Medable difference

Reusable eCOA+ Library

Our library of 380+ reusable, pre-validated instruments, assessments and diaries ensure a standardized, consistent method of data collection that drives real-time decision making.

BYOD and provisioned devices

Accessible across web and/or mobile, provisioned devices or BYOD, unlocking patient populations that were previously out of reach while increasing patients' optionality.

Cross-platform TeleVisit

One seamless platform experience allows site and patient users to better engage and participate in a comfortable environment, reducing burden and increasing compliance.

Digital measures

Standardized integrations for sensors capturing digital physiological measures provide value across a variety of therapeutic areas including Oncology, Immunology, Cardiovascular, and more.

User friendy Platform

Consumer-grade UX, complete with notifications, reports, and submission-ready data, is vetted by our Patient Caregiver Network (PCN) and clinicians, ensuring accessibility.

24/7 Customer Support

Global customer care support throughout your trial for sites, patients and study teams. Our team ensure the best user experience to enable seamless technology adoption, protocol compliance, and overall user satisfaction.

Globally Compliant

Available in 60+ countries and 120+ languages, Medable’s platform is FDA, CFR21 Part 11, HIPAA, and GDPR compliant.

Powered by AI

By harnessing intelligent automation, we can reduce delivery timelines by up to 50%, enabling an accelerated study start up to quickly capture novel endpoints.

See how Medable drove high eCOA adherence rates.

A top-10 American pharmaceutical company came to Medable looking to conduct an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites. The client was concerned about the participant experience, as the trial required participants to enroll through the master protocol before enrolling into a sub-study. Additionally, they wanted to reuse and scale the solution for future trials without compromising the site and patient experience.‍ Learn how Medable was able to accomplish this and more.‍‍

PDF
Medable platform delivers >90% eCOA adherence and scalability

Frequently asked questions

What is eCOA?

eCOA stands for electronic clinical outcome assessment and uses electronic devices like tablets, desktop computers, and phones to collect data from trial participants. Participants complete diaries, questionnaires, or other prompts to communicate how they are feeling or functioning during the course of a clinical trial. eCOAs are part of the decentralized clinical trial (DCT) methodology and are essential to understanding whether a drug is reducing symptoms and improving patients’ quality of life.

What is Medable’s eCOA offering?

Medable’s eCOA offering is part of our broader evidence generation offering: Patient-First Data Collection.  Medable’s tools allow teams to build eCOA instruments (both validated instruments and eDiaries) that meet industry standards. Data collected from this system can be used for primary endpoints in pivotal studies. Study teams can store instruments, including translations, in a library for rapid deployment in future studies. Dashboards keep teams informed of all startup activities along the way. Teams may also access their library of prebuilt, validated instruments to improve study startup.

Does Medable’s support BYOD?

Yes. Medable's platform is multimodal, meaning patients can access our interface through the Patient app or a web browser. A BYOD model allows patients to use their own smartphone or other device for data capture during a site visit or remotely. Participants using devices they are already familiar with may lead to better compliance and ultimately, a better clinical trial experience. However, since some participants may be hesitant to download an app on their own device, or may not own a device that meets the requirements, it’s important to anticipate a percentage of provisioned devices, even in trials adopting a BYOD strategy.

The latest in eCOA

White Papers, Case Studies, Reports

Explore Medable Studio

A decade ago, our founders’ experiences in clinical research and life sciences drove them to create Medable, a simple cloud-based platform that could improve theconduct of trials. Over the last ten years, we’ve conducted nearly 400 trials on our platform, continually refining it to provide a better experience for sites, patients, and caregivers.Today, we’re excited to announce that our customers are entering a new era of control, ease of use, and simplicity.

Blog posts

Control and transparency: Solving sponsors’ key challenges in study launch

There’s no doubt that study launches come with extremely high stakes for sponsors. 

This period requires precise coordination over numerous critical activities across multiple stakeholders, including regulatory bodies, ethics committees, investigator sites, and internal teams. 

Any lapses here can significantly impact the entire study timeline, budget, and, in some cases, the study’s integrity. 

Blog posts

Creating success with digital measures

The landscape of clinical trials is undergoing a significant transformation as digital measures and digital health technologies (DHTs) continue to evolve and prove their worth. 

As of December 2023, approximately 1,550 clinical trials worldwide utilized wearable devices, representing about 2% of all trials. While this percentage may seem small, it marks a steady increase since 2014, and the momentum is set to accelerate.

Discover how Studio enhances control and efficiency throughout 
study launch.